William Harris, MD, Associate Professor, Division of Oncology, University of Washington School of Medicine; Seattle Cancer Care Alliance, discusses new developments and current treatment algorithms for hepatocellular carcinoma, recent advances in systemic therapy for biliary tract cancers, and updates in the diagnosis and treatment of pancreatic cancer.

This educational activity will award continuing education hours for physicians and nurses.

Learning Objectives 

At the end of this educational activity, participants should be able to:

- Describe the latest recommendations for diagnosing, treating, and monitoring hepatobiliary, pancreatic, and gastroesophageal cancers.   

- Identify emerging strategies for improving the quality of symptom management and survivorship care for patients with hepatobiliary, pancreatic, and gastroesophageal cancers.  

- Evaluate tools and resources for managing hepatobiliary, pancreatic, and gastroesophageal cancers that can be used to achieve effective care and improve the patient experience.   

- Apply new knowledge to improve the delivery of effective and appropriate care to patients with hepatobiliary, pancreatic, and gastroesophageal cancers. 


William Harris, MD

Associate Professor, Division of Oncology University of Washington School of Medicine Seattle Cancer Care Alliance

Shane Morita, MD, PhD, FACS (Moderator)

Program Director, Surgical Oncology The Queen's Medical Center

Shane Morita, MD, MS, PhD, FACS, is the surgical oncology program director at The Queen’s Medical Center/Queen’s Cancer Center and is part of the clinical faculty for the John A. Burns School of Medicine and the University of Hawaii Cancer Center. He is actively involved in program development for the Queen’s multidisciplinary cancer clinic and conducts research centered on molecular pathways and ethnic disparity of cancer in Hawaii, including thyroid carcinoma and cutaneous melanoma.

Additionally, Dr. Morita is the incoming Chair for the State of Hawaii Comprehensive Cancer Control Coalition and an active board member of the American Cancer Society Hawaii-Pacific chapter. He has received numerous awards for his research and was the sole recipient of the NCCTG junior faculty grant from the Mayo Clinic.



The Hawaii Society of Clinical Oncology (HSCO) is a Chapter Member of the Association of Community Cancer Centers (ACCC). HSCO members receive access to valuable educational content and targeted resources through ACCC to support their professional development.

· The ACCC COVID-19 Resource Center contains webcasts, podcasts, and blogs, and resources on the pandemic from federal and professional organizations.

· The ACCC COVID-19 Financial Advocacy Resources Hub features new and updated foundation assistance, updates to manufacturer assistance programs, and Medicare and Medicaid coverage updates.

· HSCO members can connect in real-time through members-only virtual discussion forum on ACCCeXchange. Within this forum, HSCO members from every profession involved in cancer care delivery ask and answer questions, discuss common challenges, and share knowledge and experience.  Join the discussion and connect with your peers.

·  Tap into the value of HSCO membership! Visit our membership page for more information on how you can join our community of professionals. If you’re unsure of your membership status, please contact our membership department today.

· The ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. Since you’re already logged in, take a look around today!



Webinar 4: HSCO Clinical Education Series
10/02/2020 at 2:00 PM (EDT)   |  60 minutes
10/02/2020 at 2:00 PM (EDT)   |  60 minutes

Already registered?
Log in to access.

Log In